Cargando…

A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project

Neurologists managing women with Multiple Sclerosis (MS) need information about the safety of disease modifying drugs (DMDs) during pregnancy. However, this knowledge is limited. The present study aims to summarize previous studies by performing a systematic review and meta-analyses. The terms “mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Leon, Sandra, Geissbühler, Yvonne, Sabidó, Meritxell, Turkson, Moise, Wahlich, Charlotte, Morris, Joan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419441/ https://www.ncbi.nlm.nih.gov/pubmed/32444984 http://dx.doi.org/10.1007/s00415-020-09913-1

Ejemplares similares

Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project
por: Richardson, Jonathan L., et al.
Publicado: (2023)

Case Report: Bosentan and Sildenafil Exposure in Human Milk - A Contribution From the ConcePTION Project
por: Nauwelaerts, Nina, et al.
Publicado: (2022)

Development of a Pig Mammary Epithelial Cell Culture Model as a Non-Clinical Tool for Studying Epithelial Barrier—A Contribution from the IMI-ConcePTION Project
por: Bernardini, Chiara, et al.
Publicado: (2021)

Stimulating solidarity to improve knowledge on medications used during pregnancy: A contribution from the ConcePTION project
por: Hollestelle, Marieke J, et al.
Publicado: (2023)

Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project
por: Monfort, Anaëlle, et al.
Publicado: (2023)

An inventory of European data sources to support pharmacoepidemiologic research on neurodevelopmental outcomes in children following medication exposure in pregnancy: A contribution from the ConcePTION project
por: Given, Joanne, et al.
Publicado: (2022)

From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding
por: Thurin, Nicolas H., et al.
Publicado: (2021)

Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the ConcePTION Project
por: Nauwelaerts, Nina, et al.
Publicado: (2023)

Animal Models for In Vivo Lactation Studies: Anatomy, Physiology and Milk Compositions in the Most Used Non-Clinical Species: A Contribution from the ConcePTION Project
por: Ventrella, Domenico, et al.
Publicado: (2021)

Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants—A Contribution from the ConcePTION Project
por: Van Neste, Martje, et al.
Publicado: (2023)

A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project
por: Roque Pereira, Leonardo, et al.
Publicado: (2022)

A Learning Healthcare System for pregnant and breastfeeding women: what do women during preconception, pregnancy, and nursing think? – A qualitative study: A contribution from the ConcePTION project
por: Hollestelle, Marieke J., et al.
Publicado: (2022)

Correction to: A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project
por: Pereira, Leonardo Roque, et al.
Publicado: (2022)

IMI 2021 Yearly Digest
por: Jong, Monica, et al.
Publicado: (2021)

IMI Impact of Myopia
por: Sankaridurg, Padmaja, et al.
Publicado: (2021)

IMI Pathologic Myopia
por: Ohno-Matsui, Kyoko, et al.
Publicado: (2021)

IMI 2023 Digest
por: Sankaridurg, Padmaja, et al.
Publicado: (2023)

IMI – Myopia Genetics Report
por: Tedja, Milly S., et al.
Publicado: (2019)

IMI Risk Factors for Myopia
por: Morgan, Ian G., et al.
Publicado: (2021)

Erratum in: IMI Pathologic Myopia
Publicado: (2021)

Erratum in: IMI 2023 Digest
Publicado: (2023)

Adaptability and reproducibility of a memory disruption rTMS protocol in the PharmaCog IMI European project
por: Martin-Trias, Pablo, et al.
Publicado: (2018)

The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project
por: Teare, Harriet J. A., et al.
Publicado: (2018)

1460. Imipenem/Cilastatin (IMI)/Relebactam (REL) in Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia (HABP/VABP): Subgroup Analyses of Critically Ill Patients in the RESTORE-IMI 2 Trial
por: Chen, Luke F, et al.
Publicado: (2020)

Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study
por: Sabidó-Espin, Meritxell, et al.
Publicado: (2017)

IMI Accommodation and Binocular Vision in Myopia Development and Progression
por: Logan, Nicola S., et al.
Publicado: (2021)

IMI Workshop on Optimization in the Real World
por: Fujisawa, Katsuki, et al.
Publicado: (2016)

IMI Prevention of Myopia and Its Progression
por: Jonas, Jost B., et al.
Publicado: (2021)

Emergence of bla(IMI-2)- and bla(IMI-16)-Producing Enterobacter asburiae in the Aquaculture Environment of Jiangsu, China
por: Che, Jie, et al.
Publicado: (2023)

IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma?
por: Suzuki, Kazuhito, et al.
Publicado: (2023)

A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
por: Hellwig, Kerstin, et al.
Publicado: (2021)

Making the patient voice heard in a research consortium: experiences from an EU project (IMI-APPROACH)
por: Taylor, Jane, et al.
Publicado: (2021)

1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections
por: Kaye, Keith, et al.
Publicado: (2018)

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
por: Hellwig, Kerstin, et al.
Publicado: (2020)

IMiDs for myeloma induced renal impairment
por: Gavriatopoulou, Maria, et al.
Publicado: (2018)

IMI – Myopia Control Reports Overview and Introduction
por: Wolffsohn, James S., et al.
Publicado: (2019)

IMI – Report on Experimental Models of Emmetropization and Myopia
por: Troilo, David, et al.
Publicado: (2019)

IMI—Onset and Progression of Myopia in Young Adults
por: Bullimore, Mark A., et al.
Publicado: (2023)

Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry
por: Nørgaard, Mette, et al.
Publicado: (2021)

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
por: Brown, Michelle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4q51pfkcv1ugh2binq8jf4u60u